Form 4 for STRO SUTRO BIOPHARMA, INC.
Accepted 2025-10-16 00:00:00 ET · period of report 2025-10-15 · accession 0002063633-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-16 | 2025-10-15 | STRO | Pauling David | GC, Chief Admin. Ofcr | P - Purchase | $0.8 | +12.5K | 71.7K | +21% | +$10.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-15 | P | A | 12,504 | $0.8 | 71,737 | D | — | — | (F1) The reported total includes 2,500 shares of Common Stock acquired by the reporting person in one or more transactions with the Issuer pursuant to its Employee Stock Purchase Plan, which transactions are exempt pursuant to Rules 16a3(f)(1)(i)(B) and 16b3(c). |